Back to AGY.LView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Pneumococcal Infections
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
PURETHAL Mites 50,000 AUeq/mlPhase 3
House Dust Mite Allergy
Anti-HIV Immune Serum Globulin (Human)Phase 3
HIV Infections
Fluticasone Propionate, 880 mcg twice daily (after 6FED failure)Phase 3
Eosinophilic Gastrointestinal Disorders (EGIDs)
SUBLIVAC® Grasses treatmentPhase 3
Rhinitis, Allergic, Seasonal
Ragweed MATA MPLPhase 3
Type I Hypersensitivity
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts